All Stories

  1. Psychedelics: The pathway to implementation in the European healthcare systems

    Article • European Neuropsychopharmacology, January 2026, Elsevier

    Dr Henrik E. Jungaberle

  2. Key competencies for psychedelic treatment in real-world mental health care settings

    Article • General Hospital Psychiatry, November 2025, Elsevier

    Dr Henrik E. Jungaberle

  3. What Makes Psychedelic Therapy Work? Insights from Psychotherapy Research

    Article • Psychological Review, October 2025, American Psychological Association (APA)

    Max Wolff, Dr Henrik E. Jungaberle

  4. Compassionate use of psilocybin for treatment-resistant depression in Germany

    Article • The Lancet Psychiatry, September 2025, Elsevier

    Dr Henrik E. Jungaberle

  5. Einstellungen zur Einführung der psychedelischen Therapie

    Article • Nervenheilkunde, June 2024, Thieme Publishing Group

    Dr Henrik E. Jungaberle

  6. Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)

    Article • Journal of Psychopharmacology, May 2024, SAGE Publications

    Dr Henrik E. Jungaberle

  7. Treatment with psychedelics is psychotherapy: beyond reductionism

    Article • The Lancet Psychiatry, March 2024, Elsevier

    Dr Henrik E. Jungaberle

  8. Decreased CO2 saturation during circular breathwork supports emergence of altered states of consciousness

    Article • February 2024, Research Square

    Dr Henrik E. Jungaberle

  9. Decreased CO2 saturation during circular breathwork supports emergence of altered states of consciousness

    Article • February 2024, Center for Open Science

    Dr Henrik E. Jungaberle

  10. Einstellungen von Expertinnen und Experten für psychische Gesundheit gegenüber Psilocybin

    Article • Fortschritte der Neurologie · Psychiatrie, June 2022, Thieme Publishing Group

    Dr Henrik E. Jungaberle

  11. Methodological Challenges in Psychedelic Drug Trials:Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression (EPIsoDE) – Rationale and Study Design

    Article • Neuroscience Applied, March 2022, Elsevier

    Dr Henrik E. Jungaberle

  12. The Potential Role of Psychedelic Drugs in Mental Health Care of the Future

    Article • Pharmacopsychiatry, May 2021, Thieme Publishing Group

    Dr Henrik E. Jungaberle

  13. Therapie mit Psychedelika - die Rolle der Psychotherapie

    Article • NeuroTransmitter, November 2020, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  14. Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance

    Article • Frontiers in Psychiatry, February 2020, Frontiers

    Dr Henrik E. Jungaberle

  15. Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders

    Article • Psychopharmacology, February 2020, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  16. Microdosing psychedelics: Motivations, subjective effects and harm reduction

    Article • International Journal of Drug Policy, January 2020, Elsevier

    Dr Henrik E. Jungaberle

  17. Psychedelic Microdosing: A Subreddit Analysis

    Article • Journal of Psychoactive Drugs, October 2019, Taylor & Francis

    Dr Henrik E. Jungaberle

  18. The link between childhood trauma and dissociation in frequent users of classic psychedelics and dissociatives

    Article • Journal of Substance Use, May 2019, Taylor & Francis

    Dr Henrik E. Jungaberle

  19. Comparing Mental Health across Distinct Groups of Users of Psychedelics, MDMA, Psychostimulants, and Cannabis

    Article • Journal of Psychoactive Drugs, March 2019, Taylor & Francis

    Dr Henrik E. Jungaberle

  20. Positive psychology in the investigation of psychedelics and entactogens: A critical review

    Article • Neuropharmacology, June 2018, Elsevier

    Dr Henrik E. Jungaberle

  21. Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, February 2018, Elsevier

    Dr Henrik E. Jungaberle

  22. Handbuch Psychoaktive Substanzen

    Article • January 2018, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  23. Psychedelika

    Article • November 2017, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  24. Psychotherapie mit adjuvanter Gabe von serotonergen psychoaktiven Substanzen – Möglichkeiten und Hindernisse

    Article • Fortschritte der Neurologie · Psychiatrie, July 2017, Thieme Publishing Group

    Dr Henrik E. Jungaberle

  25. Psychedelika

    Article • January 2017, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  26. Handbuch Psychoaktive Substanzen

    Article • January 2017, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  27. Einführung: Auf dem Weg zu einer transdisziplinären Drug Science

    Article • January 2017, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  28. Salutogene und nicht-pathologische Formen von Substanzkonsum

    Article • January 2017, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  29. Incremental validity of sense of coherence, neuroticism, extraversion, and general self-efficacy: longitudinal prediction of substance use frequency and mental health

    Article • Health and Quality of Life Outcomes, January 2016, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  30. Die Rolle von psychoaktiven Substanzen bei Lern- und Anpassungsprozessen

    Article • January 2016, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  31. Empirische Untersuchung veränderter Bewusstseinszustände

    Article • January 2016, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  32. Pilot Evaluation Study of the Life Skills Program REBOUND

    Article • SAGE Open, December 2015, SAGE Publications

    Dr Henrik E. Jungaberle

  33. Two Patterns of Cannabis Use Among Adolescents: Results of a 10-Year Prospective Study Using a Growth Mixture Model

    Article • Substance Abuse, January 2015, Taylor & Francis

    Dr Henrik E. Jungaberle

  34. Sense of Coherence und Konsum psychoaktiver Substanzen bei Jugendlichen

    Article • Zeitschrift für Gesundheitspsychologie, January 2015, Hogrefe Publishing Group

    Dr Henrik E. Jungaberle

  35. Development of Risk Perception and Substance Use of Tobacco, Alcohol and Cannabis Among Adolescents and Emerging Adults: Evidence of Directional Influences

    Article • Substance Use & Misuse, December 2014, Taylor & Francis

    Dr Henrik E. Jungaberle

  36. REBOUND: A media-based life skills and risk education programme

    Article • Health Education Journal, November 2014, SAGE Publications

    Dr Henrik E. Jungaberle

  37. Sense of coherence and substance use: Examining mutual influences

    Article • Personality and Individual Differences, July 2014, Elsevier

    Dr Henrik E. Jungaberle

  38. The internationalisation of ayahuasca, edited by Beatriz C. Lebate and Henrik Jungaberle

    Article • Drugs Education Prevention and Policy, July 2013, Taylor & Francis

    Dr Henrik E. Jungaberle

  39. Development of salutogenetic factors in mental health - Antonovsky’s sense of coherence and Bandura’s self-efficacy related to Derogatis’ symptom check list (SCL-90-R)

    Article • Health and Quality of Life Outcomes, January 2013, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  40. The Internationalization of Ayahuasca. Vol. 16 of the series Performances: Intercultural Studies on Ritual, Play and Theatre

    Article • Journal of Psychoactive Drugs, November 2012, Taylor & Francis

    Dr Henrik E. Jungaberle

  41. Einleitung

    Article • January 2011, Springer Science + Business Media

    Dr Henrik E. Jungaberle

  42. Motive für den Konsum psychoaktiver Substanzen am Beispiel des Ayahuasca-Gebrauchs in der Santo-Daime-Gemeinschaft

    Article • Zeitschrift für Medizinische Psychologie, January 2011, IOS Press

    Dr Henrik E. Jungaberle

  43. Subjective Theories about (Self-)Treatment with Ayahuasca

    Article • Anthropology of Consciousness, August 2010, Wiley

    Dr Henrik E. Jungaberle

  44. Muster und Verlauf des Konsums psychoaktiver Substanzen im Jugendalter - Die Bedeutung von Kohärenzsinn und Risikowahrnehmung

    Article • Suchttherapie, March 2008, Thieme Publishing Group

    Dr Henrik E. Jungaberle

  45. ImPuls-Gruppe – Ein fokales zeitlich-befristetes Gruppenkonzept für Brustkrebspatientinnen

    Article • Zentralblatt für Gynäkologie, February 2004, Thieme Publishing Group

    Dr Henrik E. Jungaberle

  46. New Steps in Musical Meaning – the Metaphoric Process as an Organizing Principle

    Article • Nordic Journal of Music Therapy, January 2001, Taylor & Francis

    Dr Henrik E. Jungaberle

  47. Qualitative Drogen- und Suchtforschung — am Beispiel eines kulturpsychologischen Forschungsprojekts

    Article • Springer Science + Business Media

    Dr Henrik E. Jungaberle

  48. Konsum, Missbrauch und Abhängigkeit von psychoaktiven Substanzen

    Article • Springer Science + Business Media

    Dr Henrik E. Jungaberle